Skip to main content Accessibility help
×
Home
  • Print publication year: 2018
  • Online publication date: February 2018

Chapter 3 - Histology

Bohlen, O., and Halbach, R. D. (2002). Neurotransmitters and Neuromodulators: Handbook of Receptors and Biological Effects. New York, NY: John Wiley and Sons, Ltd.
Cowan, M. W., Südhof, T. C., and Stevens, C. F. (Eds.). (2001). Synapses. Baltimore, MD: Johns Hopkins University Press.
Ettinger, R. H. (2011). Psychopharmacology. Upper Saddle River, NJ, Prentice Hall.
Morgan, J. R., and Bloom, O. (2005). Cells of the Nervous System. Philadelphia, PA: Chelsea House Publishers.
Stanton, P. K., Bramham, C., and Scharfman, H. E. (Eds.). (2005). Synaptic Plasticity and Transsynaptic Signaling. New York, NY: Springer.
Webster, R. A. (Ed.). (2001). Neurotransmitters, Drugs and Brain Function. New York, NY: John Wiley and Sons, Ltd.
Abi-Dargham, A., and Moore, H. (2003). Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist, 9, 404416. doi:10.1177/1073858403252674
Andreasen, N. C., Nopoulos, P., O’Leary, D. S., Miller, D. D., Wassink, T., and Flaum, M. (1999). Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol. Psychiatry, 46, 908920. doi:10.1016/S0006-3223
Aroniadou-Anderjaska, V., Qashu, F., and Braga, M. F. M. (2007). Mechanisms regulating GABAergic inhibitory transmission in the basolateral amygdala: implications for epilepsy and anxiety disorders. Amino Acids, 32, 305315. doi:10.1007/s00726-006–0415-x
Aston-Jones, G., and Cohen, J. D. (2005). An integrative theory of coeruleus-norepinephrine function: Adaptive gain and optimal performance. Annu. Rev. Neurosci. 28, 403450. doi:10.1146/annurev.neuro.28.061604.135709
Bartus, R. T., Dean, R. L., Beer, B., and Lippa, A. S. (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science, 21, 408417. doi:10.1126/science.7046051
Bedlack, R. S., Traynor, B. J., and Cudkowicz, M. E. (2007). Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotrophic lateral sclerosis. Expert Opin. Emerg. Drugs., 12, 229252. doi:10.1517/14728214.12.2.229
Ben-Ari, Y. (2002). Excitatory actions of GABA during development: The nature of the nurture. Nature Rev. Neurosci., 3, 728739. doi:10.1038/nrn920
Berger-Sweeney, J. (2003). The cholinergic basal forebrain system during development and its influence on cognitive processes: important questions and potential answers. Neurosci. Behav. Rev., 27, 401411. doi:10.1016/S0149-7634(03)00070–8
Bergman, O., Åhs, F., Furmark, T., Appel, L., Linnman, C., Faria, V.,… Eriksson, E. (2014). Association between amygdala reactivity and a dopamine transporter gene polymorphism. Translational Psychiatry, 4, e420. doi:10.1038/tp.2014.50
Beveridge, T. J. R., Smith, H. R., Nader, M. A., and Porrino, L. J. (2009). Abstinence from chronic cocaine self-administration alters striatal dopamine systems in Rhesus monkeys. Neuropsychopharcol. 34 (5). doi:10.1038/npp.2008.135
Bjorntorp, P. (1995). Neuroendocrine abnormalities in human obesity. Metabolism, 44 (Suppl.#2), 3841. Retrieved from: www.ncbi.nlm.nih.gov/pubmed/7532780
Bobb, A. J., Castellanos, F. X., Addington, A. M., and Rapoport, J. L. (2005). Molecular genetic studies of ADHD: 1991 to 2004. Am. J. Med. Genetics Part B (Neuropsychiatric Genetics), 132 B, 109125. doi:10.1002/ajmg.b.30086
Bohnen, N. I., Kaufer, K. I, Ivanco, L. S., Lopresti, B., Koeppe, R. A., Davis, J. G.,… DeKosky, S. T. (2003). Cortical cholinergic function is more severely affected in Parkinsonian dementia than in Alzheimer’s disease: an in vivo positron tomography study. Arch. Neurol., 60, 17451748. doi:10.1001/archneur.60.12.1745
Boksa, P. (2012). Abnormal synaptic pruning in schizophrenia: Urban myth or reality? J. Psychiatry Neurosci., 37, 7577. doi:10.1503/jpn.120007
Bradford, A. (2009). The dopamine and glutamate theories of schizophrenia: A short review. Curr. Anaesthesia & Critical Care, 20, 240241. doi:10.1016/j.cacc.2009.07.008
Brambilla, P., Perez, J., Barale, F., Schettini, G., and Soares, J. C. (2003). GABAergic dysfunction in mood disorders. Mol. Psychiatry, 8(8), 721737. doi:10.1038/sj.mp.4001362
Brewerton, T. D. (1995). Toward a unified theory of serotonin disturbances in eating and related disorders. Psychoneuroendocrinology, 20, 561590. Retrieved from: www.ncbi.nlm.nih.gov/pubmed/8584599
Burbaeva, G. S., Boksha, I. S., Turisheneva, M. S., Vorobyeva, E. A., Savushkina, O. K., and Tereshkina, E. B. (2003). Glutamine synthetase and glutamate dehydrogenase in the prefrontal cortex of patients with schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry, 27, 675680. doi:10.1016/S0278-5846(03)00078–2
Carbonell, T., and Rama, R. (2007). Iron, oxidative stress and early neurological deterioration in ischemic stroke. Curr. Med. Chem., 14, 857874. doi:10.2174/092986707780363014
Cardon, G., Campbell, J., and Sharma, A. (2012). Plasticity in the developing auditory cortex: evidence from children with sensorineural hearing loss and auditory neuropathy spectrum disorder. J. Am. Acad. Audiol., 23, 396495. doi:10.3766/jaaa.23.6.3
Clem, R. L., Cilikel, T., and Barth, A. L. (2008). Ongoing in vivo experience triggers synaptic metaplasticity in the neocortex. Science 319, 101104. doi:10.1126/science.1143808
Cook, E. H. J., and Leventhal, B. (1996). The serotonin system in autism. Curr. Opin. Pediatr., 8, 348354.
Cortese, B. M., and Phan, K. L. (2005). The role of glutamate in anxiety and related disorders. CNS Spectrums 10, 820830. Retrieved from: www.ncbi.nlm.nih.gov/pubmed/16400245
Coyle, J. T., and Puttfarcken, P. (1993). Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689695. doi:10.1126/science.7901908
Dammann, O., and O’Shea, T. M. (2008). Cytokines and perinatal brain damage. Clin Perinatol., 35, 643663. doi:10.1016/j.clp.2008.07.011
Desai, P., Roy, M., Roy, A., Brown, S., and Smelson, D. (1997). Impaired color vision in cocaine-withdrawn patients. Arch. Gen. Psychiatry, 54, 696699. Retrieved from: www.ncbi.nlm.nih.gov/pubmed/9283503
Di Cristo, G. (2007). Development of cortical GABAergic circuits and its implications for neurodevelopmental disorders. Clin. Genet., 72, 18. doi:10.1111/j.1399–0004.2007.00822.x
Duman, R. S. (2004). Depression: A case of neuronal life and death? Biol. Psychiatry, 56, 140145. doi:10.1016/j.biopsych.2004.02.033
Dunn, A. J., Swiergiel, A. H., and Palamarchouk, V. (2004). Brain circuits involved in corticotrophin-releasing factor – norepinephrine interactions during stress. Ann. N.Y. Acad Sci., 1018, 2534. doi:10.1016/S0031-9384(03)00161–6
Ekonomou, A., Pagonopoulou, O., and Angleatau, F. (2000). Age-dependent changes in adenosine A1 receptor and uptake site binding in the mouse brain: An autoradiographic study. J. Neurosci. Res. 60, 257265. doi:10.1002/(SICI)1097–4547(20000415)60:23.0.CO;2-U
El Mansari, M., and Blier, P. (2006). Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorder. Prog. Neuro-Psychopharmacol. & Biol. Psychiatry, 30, 362373. doi:10.1016/j.pnpbp.2005.11.005
Frye, M. A., Tsai, G. E., Gouchuan, E. T., Huggins, T., Coyle, J. T., and Post, R. M. (2007). Low cerebrospinal fluid glutamate and glycine in refractory affective disorder. Biol. Psychiatry, 61, 162166. doi:10.1016/j.biopsych.2006.01.024
Gagné, A-M., Gagné, P., and Hébert, M. (2007). Impact of light therapy on rod and cone functions in healthy subjects. Psychiatry Resh., 151, 259263. doi:10.1016/j.psychres.2006.09.004
Gamkrelidze, G., Yun, S. H., and Trommer, B. L. (2005). Amyloid-β as a biologically active peptide in CNS. In Stanton, P. K., Bramham, C., and Scharfman, H. E. (Eds.) Synaptic Plasticity and Transsynaptic Signaling. (pp. 529538). New York, NY: Springer.
Gao, Z. G., and Jacobson, K. A. (2007). Emerging adenosine receptor agonists. Exp. Opin. Emerg. Drugs, 12, 479492. doi:10.1517/14728214.2011.644786
Garg, R., Ramachandran, R., and Sharma, P. (2008). Anaesthetic implications of hyperekplexia – ‘startle disease’. Anaesth. Intensive Care, 36, 254256. doi:10.1016/j.jocn.2013.03.025
Gehrmann, J., Banati, R. B., and Kreutzberg, G. W. (1993). Microglia in the immune surveillance of the brain: human microglia constitutively express HLA-DR molecules. J Neuroimmunol., 48, 189198. Retrieved from: www.ncbi.nlm.nih.gov/pubmed/8227316
Gonsette, R. E. (2008). Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis? Multiple Sclerosis, 14, 2234. doi:10.1177/1352458507080111
Gornick, M. C., Addington, A., Shaw, P., Bobb, A. J., Sharp, W., Greenstein, D.,… Rapoport, J. L. (2007). Association of the dopamine receptor D4 (DRD4) gene 7-repeat allele with children with attention-deficit/hyperactivity disorder (ADHD): An update. Am. J. Med. Genetics Part B (Neuropsychiatric Genetics), 144 B, 379382. doi:10.1002/ajmg.b.30460
Grachev, I. D., and Apkarian, A. V. 2000. Chemical mapping of anxiety in the brain of healthy human: an in-vivo 1H-MRS study on the effects of sex, age, and brain region. Hum. Brain Mapp., 11, 261272. doi:10.1002/1097–0193(200012)11:43.0.CO;2–6
Guardia, J., Catagau, A. M., Batile, F., Martin, J. C., Segura, L., Gonzalvo, B.,… Casas, M. (2000). Striatal dopaminergic D(2) receptor density measured by [(123)I]iodobenzamide SPECT in the prediction of treatment outcome of alcohol-dependent patients. Am. J. Psychiatry, 157, 127129. doi:10.1176/ajp.157.1.127
Guidotti, A., Auta, J., Davis, J. M., Dong, E., Grayson, D. R., Veldic, M.,… Costa, E. (2005). GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Psychopharmacol., 180, 191205. doi:10.1016/j.schres.2010.02.164
Gurevich, E. V., and Joyce, J. N. (1997). Alterations in the cortical serotonergic system in schizophrenia: A postmortem study. Biol. Psychiatry, 42, 529545. Retrieved from: http://europepmc.org/abstract/med/9376449
Haass, C., and Selkoe, D. J. (2007). Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid β–peptide. Nat. Rev. Mole. Cell Biol., 8, 101312. doi:10.1038/nrm2101
Hammond, J., Shan, D., Meador-Woodruff, J., and McCullumsmith, R. E. (2014). Evidence of glutamatergic dysfunction in the pathophysiology of schizophrenia. In: Popol, M., Diamond, D., and Sanacora, G. (Eds.) Synaptic Stress and Pathogenesis of Neuropsychiatric Disorders. (pp. 265294). New York, NY: Springer.
Hanson, S. M. and Czajkowski, C. (2008). Structural mechanisms underlying benzodiazepine modulation of the GABAA receptor. J. Neurosci., 28, 34903499. doi:10.1523/JNEUROSCI.5727–07.2008
Hardy, J., and Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science, 297, 353356. doi:10.1126/science.1072994
Heinz, A., Higley, J. D., Gorey, J. G., Saunders, R. C., Jones, D. W., Hommer, D.,… Linnoila, M. (1998). In vivo association between alcohol intoxication, aggression, and serotonin transporter availability in nonhuman primates. Am. J. Psychiatry, 155, 10231028. Retrieved from: http://ajp.psychiatryonline.org/doi/pdf/10.1176/ajp.155.8.1023
Hensch, T. K., and Stryker, M. P. (2004). Columnar architecture sculpted by GABA circuits in developing cat visual cortex. Science, 303, 16781681. doi:10.1126/science.1091031
Heresco-Levy, U., and Javitt, D. C. (2004). Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis. Schizophr. Res., 66, 8996. doi:10.1016/s0920-9964(03)00129–4
Hoek, R. M., Ruuls, S. R., Murphy, C. A., Wright, G. J., Goddard, R., Zurawski, S. M.,… Sedgwick, J. D. (2000). Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science, 290, 17681771. doi:10.1126 /science.290.5497.1768
Hoekstra, R., Fekkes, D., Loonen, A. J. M., Pepplinkhuizen, L., Tuineier, S., and Verhoeven, W. M. A. (2006). Bipolar mania and plasma amino acids: increased levels of glycine. Eur. Neuropsychopharmacol, 16, 7177. doi:10.1016/j.euroneuro.2005.06.003
Howes, O., McCutcheon, R., and Stone, J. (2015). Glutamate and dopamine in schizophrenia: An update for the 21st century. J. Psychopharm. 29, 97115. doi:10.1177/0269881114563634
Jacobson, K. A., and Gao, Z. G. (2006). Adenosine receptors as therapeutic targets. Nature Reviews. Drug Discovery, 5, 247264. doi:10.1007/978–3-540–89615-9_1
Jeng, J-M., and Sensi, S. L. (2005). Zinc dyshomeostasis in neuronal injury. In Stanton, P. K., Bramham, C., and Scharfman, H. E. (Eds.), Synaptic Plasticity and Transsynaptic Signaling. (pp. 139157). New York, NY: Springer.
Kamenetz, R., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T.,… Malinow, R. (2003). APP processing and synaptic function. Neuron, 37, 925937. doi:10.1016/S0896-6273(03)00124–7
Kaul, M., Garden, G. A., and Lipton, S. A. (2001). Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature, 410, 988994. doi:10.1038/35073667
Kim, W. G., Mohney, R. P., Wilson, B., Jeohn, G. H., Liu, B., and Hong, J. S. (2000). Regional difference in susceptibility to lipopolysacchride-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci., 20, 63096316. doi:10.1007/s10571-009–9477-0
Kim, Y. S., and Joh, T. H. (2006). Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson’s disease. Exp. and Mol. Med., 38, 333347. doi:10.1016/j.pneurobio.2009.08.001
Kim, Y. S., Kim, S. S., Cho, J. J., Choi, D. H., Hwang, O., Shin, D. H.,… Joh, T. H. (2005). Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia. J. Neurosci., 25, 37013711. doi:10.1523/JNEUROSCI.4346–04.2005
Kronfol, Z., and Remick, D. G. (2000). Cytokines and the brain: Implications for clinical psychiatry. Am. J. Psychiatry, 157, 683694. doi:10.1176/appi.ajp.157.5.683
Krystal, J. H., Sanacora, G., Blumberg, H., Anand, A., Charney, D. S., Marek, G.,… Mason, G. F. (2002). Glutamate and GABA systems as targets for novel antidepressant and mood stabilizing treatments. Mol. Psychiatry, 7, S71S80. doi:10.1038/sj.mp.4001021
Krystal, J. H., Staley, J., Mason, G., Petrakis, I. L., Kaufman, J., Harris, R. A.,… Lappalainen, J. (2006). γ-Aminobutyric acid type A receptors and alcoholism. Arch. Gen. Psychiatry, 63, 957968. doi:10.1001/archpsyc.63.9.957
Kugaya, A., and Sanacora, G. (2005). Beyond monoamines: glutamatergic function in mood disorders. CNS Spectrums, 10, 808819. doi:10.1017/S1092852900010403
Lane, J. H., Sasseville, V. G., Smith, M. O., Vogel, P., Pauley, D. R., Heyes, M. P., and Lackner, A. A. (1996). Neuroinvasion by simian immunodeficiency virus coincides with increased numbers of perivascular macrophages/microglia and intrathecal immune activation. J. Neurovirol., 2, 423432.
Lee, M. G., Hassani, O. K., Alonso, A., and Jones, B. E. (2005). Cholinergic basal forebrain neuron burst with theta during waking and paradoxical sleep. J. Neurosci., 25, 43654369. doi:10.1523/JNEUROSCI.0178–05.2005
Leri, F., Flores, J., Rodaros, D., and Stewart, J. (2002). Blockade of stress-induced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala. J. Neurosci., 22, 57135718. doi:10.3410/f.1008203.119312
Lewerenz, J., and Maher, P. (2015). Chronic Glutamate Toxicity in Neurodegenerative Diseases. What is the Evidence? Front. Neurosci., 9, 469. doi:10.3389/fnins.2015.00469
Liu, B., Gaom, H. M., Wangm, J. Y., Jeohnm, G. H., Cooperm, C. L., and Hong, J. S. (2002). Role of nitric oxide in inflammation-mediated neurodegeneration. Ann. N. Y. Acad. Sci., 962, 318331. doi:10.1111/j.1749–6632.2002.tb04077.x
Lucas-Meunier, E., Fossier, P., Baux, G., and Amar, M. (2003). Cholinergic modulation of the cortical neuronal network. Plugers Arch., 446, 1729. doi:10.1007/s00424-002–0999-2
Machado-Vieira, R., Henter, I. D., and Zarate, C. A. Jr. (2015). New targets for rapid antidepressant action. Prog. Neurobiol., online Dec. 23, S0301-0082(15)30038–1. doi:10.1016/j.pneurobio.2015.12.001
Maron, E., and Shlik, J. (2006). Serotonin function in panic disorder: important, but why? Neuropsychopharmacol., 31, 111. doi:10.1038/sj.npp.1300880
Marrone, D. F. (2007). Ultrastructural plasticity associated with hippocampal-dependent learning: a meta-analysis. Neurobiol. Learn. Mem., 87, 361371. doi:10.1016/j.nlm.2006.10.001
Meltzer, C. C., Smith, G., DeKosky, S. T., Pollock, B. G., Mathis, C. A., Moore, R. Y.,… Reynolds, C. F. 3rd (1998). Serotonin in aging, late-life depression, and Alzheimer’s disease: The emerging role of functional imaging. Neuropsychopharmacol., 18, 407430. Retrieved from: www.ncbi.nlm.nih.gov/pubmed/9571651
Menza, M. A., Golve, L. I., Cody, R. A., and Forman, N. E. (1993). Dopamine-related personality traits in Parkinson’s disease. Neurology, 43, 505508. doi:10.1212/WNL.43.3_Part_1.505
Moore, R. Y., and Bloom, F. E., 1979. Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems. Ann. Rev. Neurosci., 2, 113168. doi:10.1146/annurev.ne.02.030179.000553
Nagatsu, T., and Sawada, M. (2005). Inflammatory process in Parkinson’s disease: role for cytokines. Cur. Pharma. Design, 11, 9991016. doi:10.2174/1381612053381620
New, A. S., and Siever, L. J. (2003). Biochemical endophenotypes in personality disorders. Methods Mol. Med., 77, 199213. doi:10.1385/1–59259-348–8:199
Niizato, K., Iritani, S., Ikeda, K., and Arai, H. (2001). Astroglial function of schizophrenic brain: a study using lobotomized brain. Clin. Neurosci. Neuropathol., 12, 14571460. doi:10.1097/00001756–200105250-00032
Nudmamud-Thanoi, S., and Reynolds, G. P. (2004). The NR1 subunit of the glutamate/NMDA receptor in the superior temporal cortex in schizophrenia and affective disorders. Neurosci. Let., 372, 173177. doi:10.1016/j.neulet.2004.09.035
Nutt, D. (2006). GABAA receptors: subtypes, regional distribution, and function. J. Clin. Sleep Med., 2, S7S11. doi:10.1016/j.neuropharm.2008.07.045
Olanow, C. W. (2007). The pathogenesis of cell death in Parkinson’s disease – 2007. Movement Disorders 22, S17, S335342. doi:10.1002/mds.21675
Olney, J. W., and Farber, N. B. (1995). Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiat., 52, 9981007. Retrieved from: www.ncbi.nlm.nih.gov/pubmed/7492260
Partonen, T. (1996). Dopamine and circadian rhythms in seasonal affective disorder. Med. Hypotheses, 47, 191192. doi:10.1016/S0306-9877(96)90079–1
Perlov, E., Philipsen, A., Hesslinger, B., Buechert, M., Ahrendts, J., Feige, B.,… van Elst, L. (2007). Reduced cingulate glutamate/glutamine-to-creatine ratios in adult patients with attention deficit/hyperactivity disorder – a magnet resonance spectroscopy study. J. Psychiatric Res., 41, 934941. doi:10.3109/15622970801958331
Phan, K. L, Fitzgerald, D. A., Cortese, B. M., Seraji-Bozorgzad, N., Tancer, M. E., and Moore, G. J. (2005). Anterior cingulate neurochemistry in social anxiety disorder: 1H-MRS at 4 Tesla. Neuroreport, 16, 183186. doi:10.1097/00001756–200502080-00024
Plant, L. D., Boyle, J. P., Smith, I. F., Peers, C., and Pearson, H. A. (2003). The production of amyloid beta peptide is a critical requirement for the viability of central neurons. J. Neurosci., 23, 55315535. doi:10.1016/j.neulet.2009.12.035
Pliszka, S. R. (2005). The neuropsychopharmacology of attention-deficit/hyperactivity disorder. Biol. Psychiatry, 57, 13851390. doi:10.1038/npp.2009.120
Quiroz, J. A., Singh, J., Gould, T. D., Denicoff, K. D., Zarate, C. A., and Manji, H. K. (2004). Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology. Mol. Psychiatry, 9, 756776. doi:10.1038/sj.mp.4001521
Raedler, T. J., Bymaster, F. P, Tandon, R., Copolov, D., and Dean, B. (2007). Towards a muscarinic hypothesis of schizophrenia. Mol. Psychiatry, 12, 232246. doi:10.1017/S1461145706006584
Raine, C. S. (1994). Multiple sclerosis: immune system molecule expression in the central nervous system. J. Neuropathol. Exp. Neurol., 53, 328337. Retrieved from: www.ncbi.nlm.nih.gov/pubmed/8021705
Réus, G. Z., Fries, G. R., Stertz, L., Baawy, M., Passos, I. C., Barichello, T., Kapczinski, F., and Quevedo, J. (2015). The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders. Neurosci., 300, 141154. doi:10.1016/j.neuroscience.2015.05.018
Rocchettia, J., Isingrinia, E., Dal Boa, G., Saghebya, S., Menegauxa, A., Troncheb, F.,… Girosa, B. (2014) Presynaptic D2 dopamine receptors control long-term depression and memory processes in the temporal hippocampus. Biol. Psychiatry, 77, 513525. doi:10.1016/j.biopsych.2014.03.013
Rossner, S., Schultz, I., Zeitschel, U., Schliebs, R., Bigl, V., and Denmuth, H. V. (2005). Brain propyl endopeptidase expression in aging, APP transgenic mice and Alzheimer’s disease. Neurochem. Res., 30, 695702. doi:10.1007/s11064-005–6863-y
Rothman, D. L., Behar, K. L., Hyder, F., and Shulman, R. G. (2003). In vivo NMR studies of the glutamate neurotransmitter flux and neuroenergetics: implications for brain function. Annu. Rev. Physiol., 65, 401427. doi:10.1146/annurev.physiol.65.092101.142131
Sakae, D. Y., Marti, F., Lecca, S., Vorspan, F., Martin-Garcia, E., Morel, L. J.,… El Mestikaway, S. (2015). The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens. Mol. Psychiatry, 20, 14481459. doi:10.1038/mp.2015.104
Salmond, C. H., Chatfield, D. A., Menon, D. K., Pickard, J. D., and Sahakian, B. J. (2005). Cognitive sequelae of head injury: involvement of basal forebrain and associated structures. Brain, 128, 189200. doi:10.1093/brain/awh352
Sanacora, G., Zarate, C. A., Krystal, J. H., and Manji, H. K. (2008). Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat. Rev. Drug Discov., 7, 426437. doi:10.1038/nrd2462
Sarika, Arora, A. (2006) Role of neuropeptides in appetite regulation and obesity – A review. Neuropeptides, 40(6), 375401. doi:10.1016/j.npep.2006.07.001
Sato, A., Sato, Y., and Uchida, S. (2004). Activation of the intracerebral cholinergic nerve fibers originating in the basal forebrain increases regional cerebral blood flow in the rat’s cortex and hippocampus. Neurosci. Let., 361, 9093. doi:10.1016/j.neulet.2004.01.004
Schildkraut, J. J. (1965). The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am. J. Psychiatry, 122, 509522. Retrieved from: http://ajp.psychiatryonline.org/doi/abs/10.1176/ajp.122.5.509
Schliebs, R., and Arendt, T. (2006). The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease. J. Neural. Transm., 113, 16251644. doi:10.1016/j.bbr.2010.11.058
Schmidt, M. (2008). GABA(C) receptors in retina and brain. Results and Problems in Cell Differentiation, 44, 4967. doi:10.1007/400_2007_031
Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T.,… Wigler, M. 2007. Strong association of de novo copy number mutations with autism. Science, 316, 445449. doi:10.1126/science.1138659
Segal, M., and Bloom, F. E. (1976). The action of norepinephrine in the rat hippocampus. IV. The effects of locus coeruleus stimulation on evoked hippocampal unit activity. Brain Res., 107, 513525.
Sekier, I., Sensi, S. L., Hershfinkel, M., and Silverman, W. F. (2007). Mechanism and regulation of cellular zinc transport. Mol. Medicine, 13, 337343. doi:10.2119/2007–00037
Selkoe, D. J. (2002). Alzheimer’s disease is a synaptic failure. Science, 298, 789791. doi:10.1126/science.1074069
Shigeri, Y., Seal, R. P., and Shimamoto, K. (2004). Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Brain Resh. Rev., 45, 250265. doi:10.1016/j.brainresrev.2004.04.004
Shim, S. S., Hammonds, M. D., and Kee, B. S. (2008). Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site. Eur. Arch. Psychiatry Clin. Neurosci., 258, 1627. doi:10.1113/jphysiol.2009.168757
Siciliano, C. A., Ferris, M. J., and Jones, S. R. (2015). Cocaine self-administration disrupts mesolimbic dopamine circuit function and attenuates dopaminergic responsiveness to cocaine. Eur. J. Neurosci., 42, 20912096. doi:10.1111/ejn.12970
Spencer, K. M., Nestor, P. G., Perlmutter, R., Niznikiewicz, M. A., Klump, M. C., Frumin, M.,… McCarley, R. W. (2004). Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc. Natl. Acad. Sci. U.S.A., 101, 17288170293. doi:10.1073/pnas.0406074101
Stahl, S. M. (2007). Beyond the dopamine hypothesis to the NMDA glutamate hypofunction hypothesis of schizophrenia. CNS Spectrums, 12, 265268. doi:10.3389/fphar.2012.00195
Steiger, H., Koerner, N., Engelberg, M. J., Israel, M., Ng Ying Kin, N. M., and Young, S. N. (2001). Self-destructiveness and serotonin function in bulimia nervosa. Psychiatry Res., 103, 1526. doi:10.1016/S0165-1781(01)00264–5
Streeter, C. E., Jensen, J. E., Perlmutter, R. M., Cabral, H. J., Tian, H., Terhune, D. B.,… Renshaw, P. F. (2007). Yoga asana sessions increase brain GABA levels: a pilot study. J. Altern. Complement. Med., 13, 419426. doi:10.1089/acm.2007.6338
Terry, R. D. and Buccafusco, J. J. (2003). The cholinergic hypothesis of age and Alzheimer’s disease-related cognitive deficits: recent challenges and their implications for novel drug development. J. Pharmacol. Exp. Ther., 306, 821827. doi:10.1124/jpet.102.041616
Toledano, A., and Alvarez, M. I. (2004). Lesions and dysfunctions of the nucleus basalis as Alzheimer’s disease models: general and critical overview and analysis of the long-term changes in several excitotoxic models. Curr. Alzheimer Resh., 1, 189214. doi:10.2174/1567205043332117
Ullian, E. M., Sapperstein, S. K., Christopherson, K. S., and Barres, B. A. (2001). Control of synapse number by glia. Science, 291, 657661. doi:10.1126/science.291.5504.657
Unis, A. S., Cook, E. H., Vincent, J. G., Gjerde, D. K., Perry, B. D., Mason, C., and Mitchell, J. (1997). Platelet serotonin measures in adolescents with conduct disorder. Biol. Psychiatry, 42, 553559. Retrieved from: www.ncbi.nlm.nih.gov/pubmed/9376451
Volkow, N. D., and Wise, R. A. (2005). How can drug addiction help us understand obesity? Nat. Neurosci., 8, 555560. doi:10.1038/nn1452
Whitton, P. S. (2007). Inflammation as a causative factor in the aetiology of Parkinson’s disease. Brit. J. Pharmacology, 150, 963976. doi:10.1038/sj.bjp.0707167
Yamagata, M., Sanes, J. R., and Weiner, J. A. (2003). Synaptic adhesion molecules. Curr. Opinion in Cell Biol., 15, 621632. doi:10.1007/978–3-7091–0932-8_5
Yan, Q. S., Zheng, S. Z., and Yan, S. E. (2004). Involvement of 5-HT1B receptors within the ventral tegmental area in regulation of mesolimbic dopaminergic neuronal activity via GABA mechanisms: a study with dual-probe microdialysis. Brain Res., 1021(1), 8291. doi:10.1016/j.neuroscience.2011.05.068
Yanai, K., and Tashiro, M. (2007). The physiological and pathophysiological roles of neuronal histamine: an insight from human positron emission tomography studies. Pharmacology & Therapeutics, 113, 115. doi:10.1152/physrev.00043.2007
Yang, Y., Ge, W., Chen, Y., Zhang, Z., Shen, W., Wu, C.,… Duan, S. (2003). Contribution of astrocytes to hippocampal long-term potentiation through release of D-serine. Proc. Nat. Acad. Sci. U.S.A., 100, 1519415199. doi:10.1073/pnas.2431073100
Yoder, K. K., Kareken, D. A., Seyoum, R. A., O’Connor, S. J., Wang, C., Zheng, Q-H.,… Morris, E. D. (2005). Dopamine D2 receptor availability is associated with subjective responses to alcohol. Alcohol Clin. Exp. Res., 29, 965970. doi:10.1097/01.ALC.0000171041.32716.42